验证数据展示
经过测试的应用
Positive WB detected in | HEK-293 cells, HeLa cells, Jurkat cells |
Positive IHC detected in | human lung cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 3 publications below |
产品信息
10646-1-AP targets HIF1AN in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
经测试应用 | WB, IHC, ELISA Application Description |
文献引用应用 | WB |
经测试反应性 | human, mouse, rat |
文献引用反应性 | human, rat |
免疫原 | HIF1AN fusion protein Ag0997 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | hypoxia inducible factor 1, alpha subunit inhibitor |
别名 | Factor inhibiting HIF 1, FIH 1, FIH1, HIF1AN |
计算分子量 | 40 kDa |
观测分子量 | 40 kDa |
GenBank蛋白编号 | BC007719 |
基因名称 | HIF1AN |
Gene ID (NCBI) | 55662 |
RRID | AB_2232963 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q9NWT6 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
HIF1AN (Hypoxia-inducible factor 1-alpha inhibitor) is also named FIH1. It is identified as a molecular oxygen-dependent dioxygenase that blunts the transcriptional activity of HIF and has also been implicated in HIF-dependent and -independent hypoxia responses(PMID:20720525). Structural studies indicate that an FIH-1 homodimer forms in solution and is essential for FIH-1 activity(PMID:16154531).
实验方案
Product Specific Protocols | |
---|---|
WB protocol for HIF1AN antibody 10646-1-AP | Download protocol |
IHC protocol for HIF1AN antibody 10646-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Bioact Mater Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds. | ||
Am J Cancer Res Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development. | ||
Heliyon LncRNA OIP5-AS1 regulates ferroptosis and mitochondrial dysfunction-mediated apoptosis in spinal cord injury by targeting the miR-128-3p/Nrf2 axis |